51Chromium survival of Yt(a+) red cells as a determinant of the in vivo significance of anti‐Yta
- 12 November 1981
- journal article
- research article
- Published by Wiley in Transfusion
- Vol. 21 (6) , 702-705
- https://doi.org/10.1046/j.1537-2995.1981.21682085759.x
Abstract
A case is presented in which anti-Yta produced a moderately accelerated removal of 51Cr-labeled Yt(a+) red blood cells (T1/2, 96 h). Other reported examples of anti-Yta either have rapidly removed transfused Yt(a+) red blood cells or have permitted apparently normal survival of these cells. In light of this wide variation in in vivo potency of anti-Yta, it is recommended that 51Cr red blood cell survival studies be done before transfusion of Yt(a+) red blood cells in sensitized individuals.This publication has 10 references indexed in Scilit:
- The Clinical Significance of Anti‐H in an Individual with the Oh (Bombay) PhenotypeTransfusion, 1978
- Compatibility Test Using 51Chromium‐Labeled Red Blood Cells in Crossmatch Positive PatientsTransfusion, 1978
- Rapid in Vivo Destruction of Yt(a+) Erythrocytes in a Recipient with Anti‐YtaTransfusion, 1977
- A Second Example of Anti‐Yta with Rapid in vivo Destruction of Yt(a+) Red CellsVox Sanguinis, 1974
- Recommended Methods for Radioisotope Red Cell Survival StudiesBlood, 1971
- Clinical Experience with Three Examples of Anti‐Yta1Vox Sanguinis, 1968
- Rapid in vivo Destruction of Yt(a+) Red Cells in a Patient with Anti‐Yta1Vox Sanguinis, 1968
- Studies on the Yt Blood Group SystemVox Sanguinis, 1967
- A Further Example of Anti‐YtaVox Sanguinis, 1965
- A New Antibody, Anti‐Yta, Characterizing a Blood‐group Antigen of High IncidenceBritish Journal of Haematology, 1956